Your browser doesn't support javascript.
loading
Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Álamo III" retrospective study.
Márquez-Rodas, Iván; Pollán, Marina; Escudero, María José; Ruiz, Amparo; Martín, Miguel; Santaballa, Ana; Martínez Del Prado, Purificación; Batista, Norberto; Andrés, Raquel; Antón, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnación; González, Sonia; Seguí, Miguel Angel; Calvo, Lourdes; Lizón, José; Rodríguez Lescure, Álvaro; Ramón Y Cajal, Teresa; Llort, Gemma; Jara, Carlos; Carrasco, Eva; López-Tarruella, Sara.
Afiliação
  • Márquez-Rodas I; Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Pollán M; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Escudero MJ; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Ruiz A; Instituto de Salud Carlos III, Madrid, Spain.
  • Martín M; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Santaballa A; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Martínez Del Prado P; Servicio de Oncología Médica, Instituto Valenciano de Oncología, Valencia, Spain.
  • Batista N; Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
  • Andrés R; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Antón A; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Llombart A; Servicio de Oncología Médica, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Fernandez Aramburu A; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Adrover E; Servicio de Oncología Médica, Hospital de Basurto-Osakidetza, Bilbao, Spain.
  • González S; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Seguí MA; Servicio de Oncología Médica, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
  • Calvo L; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Lizón J; Servicio de Oncología Médica, Hospital Lozano Blesa, Zaragoza, Spain.
  • Rodríguez Lescure Á; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Ramón Y Cajal T; Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Llort G; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • Jara C; Servicio de Oncología Médica, Hospital Arnau de Vilanova, Valencia, Spain.
  • Carrasco E; Spanish Breast Cancer Research Group (GEICAM), San Sebastian de los Reyes, Spain.
  • López-Tarruella S; Sección de Oncología Médica, Complejo Universitario de Albacete, Albacete, Spain.
PLoS One ; 12(10): e0184181, 2017.
Article em En | MEDLINE | ID: mdl-28985233
ABSTRACT

PURPOSE:

To determine the frequency of breast cancer (BC) patients with hereditary risk features in a wide retrospective cohort of patients in Spain.

METHODS:

a retrospective analysis was conducted from 10,638 BC patients diagnosed between 1998 and 2001 in the GEICAM registry "El Álamo III", dividing them into four groups according to modified ESMO and SEOM hereditary cancer risk criteria Sporadic breast cancer group (R0); Individual risk group (IR); Familial risk group (FR); Individual and familial risk group (IFR) with both individual and familial risk criteria.

RESULTS:

7,641 patients were evaluable. Of them, 2,252 patients (29.5%) had at least one hereditary risk criteria, being subclassified in FR 1.105 (14.5%), IR 970 (12.7%), IFR 177 (2.3%). There was a higher frequency of newly diagnosed metastatic patients in the IR group (5.1% vs 3.2%, p = 0.02). In contrast, in RO were lower proportion of big tumors (> T2) (43.8% vs 47.4%, p = 0.023), nodal involvement (43.4% vs 48.1%, p = 0.004) and lower histological grades (20.9% G3 for the R0 vs 29.8%) when compared to patients with any risk criteria.

CONCLUSIONS:

Almost three out of ten BC patients have at least one hereditary risk cancer feature that would warrant further genetic counseling. Patients with hereditary cancer risk seems to be diagnosed with worse prognosis factors.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Predisposição Genética para Doença Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Predisposição Genética para Doença Idioma: En Ano de publicação: 2017 Tipo de documento: Article